As of December 2024, Ultragenyx Pharmaceutical has a market cap of $3.63B. This makes Ultragenyx Pharmaceutical the world's 3429th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.78B | -3.62% |
2023 | $3.93B | 3.22% |
2022 | $3.80B | -44.90% |
2021 | $6.90B | -39.25% |
2020 | $11.37B | 224.12% |
2019 | $3.51B | -1.77% |
2018 | $3.57B | -6.25% |
2017 | $3.81B | -34.03% |
2016 | $5.77B | -37.32% |
2015 | $9.21B | 155.65% |
2014 | $3.60B | - |